Cynarin alleviates intervertebral disc degeneration via protecting nucleus pulposus cells from ferroptosis DOI Open Access
Pu Zhang,

Kewei Rong,

Jiadong Guo

и другие.

Biomedicine & Pharmacotherapy, Год журнала: 2023, Номер 165, С. 115252 - 115252

Опубликована: Авг. 2, 2023

Intervertebral disc degeneration (IVDD) leads to a series of degenerative spine diseases. Clinical treatment IVDD is mainly surgery, lacking effective drugs alleviate intervertebral degeneration. In this study, we analysed the mRNA sequencing dataset human tissues and revealed participation ferroptosis in IVDD. Furthermore, confirmed that TNF-α, an important cytokine IVDD, induces nucleus pulposus cells. Subsequently, inhibitors screening strategy using multiple indicators was developed. Through screen various natural compounds, cynarin, product enriched Artichoke, discovered inhibit Cynarin can dose-dependently catabolism cells, increase expression key ferroptosis-inhibiting genes (GPX4 NRF2), increment cellular Fe2+, lipid peroxides, reactive oxygen species. It also prevent mitochondria shrinkage, reduce cristae density ferroptosis, rat model. conclusion, cynarin potential candidate for drug development

Язык: Английский

The cell biology of ferroptosis DOI
Scott J. Dixon, James A. Olzmann

Nature Reviews Molecular Cell Biology, Год журнала: 2024, Номер 25(6), С. 424 - 442

Опубликована: Фев. 16, 2024

Язык: Английский

Процитировано

266

Regulation of ferroptosis by lipid metabolism DOI Creative Commons

Lauren E. Pope,

Scott J. Dixon

Trends in Cell Biology, Год журнала: 2023, Номер 33(12), С. 1077 - 1087

Опубликована: Июль 3, 2023

Язык: Английский

Процитировано

211

Ferroptosis in cancer: From molecular mechanisms to therapeutic strategies DOI Creative Commons
Qian Zhou,

Yu Meng,

Daishi Li

и другие.

Signal Transduction and Targeted Therapy, Год журнала: 2024, Номер 9(1)

Опубликована: Март 8, 2024

Ferroptosis is a non-apoptotic form of regulated cell death characterized by the lethal accumulation iron-dependent membrane-localized lipid peroxides. It acts as an innate tumor suppressor mechanism and participates in biological processes tumors. Intriguingly, mesenchymal dedifferentiated cancer cells, which are usually resistant to apoptosis traditional therapies, exquisitely vulnerable ferroptosis, further underscoring its potential treatment approach for cancers, especially refractory cancers. However, impact ferroptosis on extends beyond direct cytotoxic effect cells. induction not only inhibits but also promotes development due negative anticancer immunity. Thus, comprehensive understanding role crucial successful translation therapy from laboratory clinical applications. In this review, we provide overview recent advancements cancer, covering molecular mechanisms, functions, regulatory pathways, interactions with microenvironment. We summarize applications immunotherapy, radiotherapy, systemic therapy, well inhibition various conditions. finally discuss markers, current challenges future directions cancer.

Язык: Английский

Процитировано

141

Targeting epigenetic and posttranslational modifications regulating ferroptosis for the treatment of diseases DOI Creative Commons
Yumin Wang, Jing Hu, Shuang Wu

и другие.

Signal Transduction and Targeted Therapy, Год журнала: 2023, Номер 8(1)

Опубликована: Дек. 10, 2023

Abstract Ferroptosis, a unique modality of cell death with mechanistic and morphological differences from other modes, plays pivotal role in regulating tumorigenesis offers new opportunity for modulating anticancer drug resistance. Aberrant epigenetic modifications posttranslational (PTMs) promote resistance, cancer progression, metastasis. Accumulating studies indicate that can transcriptionally translationally determine vulnerability to ferroptosis functions as driver nervous system diseases (NSDs), cardiovascular (CVDs), liver diseases, lung kidney diseases. In this review, we first summarize the core molecular mechanisms ferroptosis. Then, roles processes, including histone PTMs, DNA methylation, noncoding RNA regulation such phosphorylation, ubiquitination, SUMOylation, acetylation, ADP-ribosylation, are concisely discussed. The PTMs genesis cancers, NSD, CVDs, well application PTM modulators therapy these then discussed detail. Elucidating mediated by will facilitate development promising combination therapeutic regimens containing or PTM-targeting agents inducers be used overcome chemotherapeutic resistance could prevent addition, highlight potential approaches chemoresistance halt

Язык: Английский

Процитировано

72

Regulation of antioxidants in cancer DOI Creative Commons
Fábio Hecht, Marco Zocchi,

Fatemeh Alimohammadi

и другие.

Molecular Cell, Год журнала: 2023, Номер 84(1), С. 23 - 33

Опубликована: Ноя. 28, 2023

Язык: Английский

Процитировано

46

Emergence of large-scale cell death through ferroptotic trigger waves DOI Creative Commons
Hannah K. C. Co, Chia‐Chou Wu, Yi‐Chen Lee

и другие.

Nature, Год журнала: 2024, Номер 631(8021), С. 654 - 662

Опубликована: Июль 10, 2024

Abstract Large-scale cell death is commonly observed during organismal development and in human pathologies 1–5 . These events extend over great distances to eliminate large populations of cells, raising the question how can be coordinated space time. One mechanism that enables long-range signal transmission trigger waves 6 , but this might used for remains unclear. Here we demonstrate ferroptosis, an iron- lipid-peroxidation-dependent form death, propagate across cells long (≥5 mm) at constant speeds (around 5.5 μm min −1 ) through reactive oxygen species (ROS). Chemical genetic perturbations indicate a primary role ROS feedback loops (Fenton reaction, NADPH oxidase signalling glutathione synthesis) controlling progression ferroptotic waves. We show introducing stress suppression cystine uptake activates these loops, converting cellular redox systems from being monostable bistable thereby priming become media which propagate. Furthermore, ferroptosis its propagation accompany massive, yet spatially restricted, muscle remodelling embryonic avian limb, substantiating use as tissue-sculpting strategy embryogenesis. Our findings highlight coordinating global events, providing paradigm investigating large-scale pathologies.

Язык: Английский

Процитировано

36

The mechanisms of ferroptosis and its role in atherosclerosis DOI Open Access

Xi Xu,

Xiaodan Xu, Mengqing Ma

и другие.

Biomedicine & Pharmacotherapy, Год журнала: 2024, Номер 171, С. 116112 - 116112

Опубликована: Янв. 2, 2024

Ferroptosis is a newly identified form of non-apoptotic programmed cell death, characterized by the iron-dependent accumulation lethal lipid reactive oxygen species (ROS) and peroxidation membrane polyunsaturated fatty acid phospholipids (PUFA-PLs). unique among other death modalities in many aspects. It initiated excessive oxidative damage due to iron overload compromised antioxidant defense systems, including system Xc-/ glutathione (GSH)/glutathione peroxidase 4 (GPX4) pathway GPX4-independent pathways. In past ten years, ferroptosis was reported play critical role pathogenesis various cardiovascular diseases, e.g., atherosclerosis (AS), arrhythmia, heart failure, diabetic cardiomyopathy, myocardial ischemia-reperfusion injury. Studies have dysfunctional metabolism abnormal expression profiles ferroptosis-related factors, iron, GSH, GPX4, ferroportin (FPN), SLC7A11 (xCT), as indicators for atherogenesis. Moreover, plaque cells, i.e., vascular endothelial (VEC), macrophage, smooth muscle (VSMC), positively correlate with atherosclerotic development. Many macromolecules, drugs, Chinese herbs, food extracts can inhibit atherogenic process suppressing cells. contrast, some inducers significant pro-atherogenic effects. However, mechanisms through which affects progression AS still need be well-known. This review summarizes molecular their emerging AS, aimed at providing novel, promising druggable targets anti-AS therapy.

Язык: Английский

Процитировано

35

Pharmacological activation of GPX4 ameliorates doxorubicin-induced cardiomyopathy DOI Creative Commons
Chuying Huang, Yishan Guo, Tuo Li

и другие.

Redox Biology, Год журнала: 2024, Номер 70, С. 103024 - 103024

Опубликована: Янв. 10, 2024

Due to the cardiotoxicity of doxorubicin (DOX), its clinical application is limited. Lipid peroxidation caused by excessive ferrous iron believed be a key molecular mechanism DOX-induced cardiomyopathy (DIC). Dexrazoxane (DXZ), an chelator, only drug approved FDA for reducing DIC, but it has many side effects and cannot used as preventive in practice. Single-nucleus RNA sequencing (snRNA-seq) analysis identified myocardial epithelial cells that are susceptible ferroptosis. The glutathione peroxidase 4 (GPX4) activator selenomethione (SeMet) significantly reduced polyunsaturated fatty acids (PUFAs) oxidized lipid levels vitro. Consistently, SeMet decreased H9C2 mortality C57BL/6 mice compared DXZ, ferrostatin-1, normal saline. can effectively reduce serum markers cardiac injury breast cancer patients. Depletion GPX4 gene resulted increase acid (PUFA) eliminated protective effect against DIC. Notably, exerted antitumor on models with DOX while providing protection same animal without detectable toxicities. These findings suggest pharmacological activation valuable promising strategy preventing doxorubicin.

Язык: Английский

Процитировано

21

PHLDA2-mediated phosphatidic acid peroxidation triggers a distinct ferroptotic response during tumor suppression DOI
Xin Yang, Zhe Wang, Svetlana N. Samovich

и другие.

Cell Metabolism, Год журнала: 2024, Номер 36(4), С. 762 - 777.e9

Опубликована: Фев. 2, 2024

Язык: Английский

Процитировано

19

Augmented ERO1α upon mTORC1 activation induces ferroptosis resistance and tumor progression via upregulation of SLC7A11 DOI Creative Commons
Zixi Wang,

Huaiyuan Zong,

Weiwei Liu

и другие.

Journal of Experimental & Clinical Cancer Research, Год журнала: 2024, Номер 43(1)

Опубликована: Апрель 13, 2024

The dysregulated mechanistic target of rapamycin complex 1 (mTORC1) signaling plays a critical role in ferroptosis resistance and tumorigenesis. However, the precise underlying mechanisms still need to be fully understood. Endoplasmic reticulum oxidoreductase alpha (ERO1α) expression mTORC1-activated mouse embryonic fibroblasts, cancer cells, laryngeal squamous cell carcinoma (LSCC) clinical samples was examined by quantitative real-time PCR (qRT-PCR), western blotting, immunofluorescence (IF), immunohistochemistry. Extensive vitro vivo experiments were carried out determine ERO1α its downstream target, member 11 solute carrier family 7 (SLC7A11), mTORC1-mediated proliferation, angiogenesis, resistance, tumor growth. regulatory mechanism on SLC7A11 investigated via RNA-sequencing, cytokine array, an enzyme-linked immunosorbent assay, qRT-PCR, IF, luciferase reporter chromatin immunoprecipitation assay. combined therapeutic effect inhibition inducer imidazole ketone erastin (IKE) cells evaluated using line-derived xenografts, LSCC organoids, patient-derived xenograft models. is functional mTORC1. Elevated induced exerted pro-oncogenic roles upregulation SLC7A11. Mechanically, stimulated transcription activating interleukin-6 (IL-6)/signal transducer activator 3 (STAT3) pathway. Moreover, with treatment IKE exhibited synergistic antitumor effects tumors. ERO1α/IL-6/STAT3/SLC7A11 pathway crucial for growth, combining inducers novel effective mTORC1-related

Язык: Английский

Процитировано

16